Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
samedi, septembre 26
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Jaguar Health Inc
JAGX
NASDAQ
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$7.70
0.64
9.07%
À la clôture: Sep 25, 5:00 PM EST
$7.19
-0.51
-6.62%
Après les heures: 7:59 PM EST
Get Report
PRO
Pourquoi cela bouge-t-il ?:
Jaguar Health shares are trading higher after the company announced debt-fo...
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
Jaguar Health Financials
Jaguar Health (JAGX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Jaguar Health Q2 EPS $(15.70) Up From $(358.94) YoY, Sales $1.225M Down From $2.979M YoY
Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(15.70) per share. This is a 95.63 percent increase over losses of $(358.94) per share from the same period last year. The company reported $1.225 million in
Benzinga Newsdesk
PRO
Jaguar Health Q1 EPS $(13.60) Misses $(4.26) Estimate, Sales $20.272M Beat $4.211M Estimate
Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(13.60) per share which missed the analyst consensus estimate of $(4.26) by 219.25 percent. This is a 97.67 percent increase over losses of $(584.45) per share
Benzinga Newsdesk
PRO
Jaguar Health Q3 EPS $(6.28) Misses $(5.08) Estimate, Sales $3.083M Miss $3.730M Estimate
Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(6.28) per share which missed the analyst consensus estimate of $(5.08) by 23.62 percent. This is a 76.08 percent increase over losses of $(26.25) per share from
Benzinga Newsdesk
PRO
Jaguar Health Q2 2025 EPS $(10.25) Misses $(7.13) Estimate, Sales $2.979M Miss $3.265M Estimate
Benzinga Newsdesk
Earnings Scheduled For August 14, 2025
Benzinga Insights
Earnings Preview For Jaguar Health
Benzinga Insights
Privacy Manager